<SEC-DOCUMENT>0001654954-19-010402-index.html : 20190905 <SEC-HEADER>0001654954-19-010402.hdr.sgml : 20190905 <ACCEPTANCE-DATETIME>20190905161719 ACCESSION NUMBER: 0001654954-19-010402 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20190905 DATE AS OF CHANGE: 20190905 EFFECTIVENESS DATE: 20190905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-233636 FILM NUMBER: 191077388 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>tgtx_s3asr.htm <DESCRIPTION>FORM S-3ASR <TEXT> Document 1 - file: tgtx_s3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4 <SEQUENCE>2 <FILENAME>tgtx_ex41.htm <DESCRIPTION>EXHIBIT 4.1 <TEXT> Document 2 - file: tgtx_ex41.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5 <SEQUENCE>3 <FILENAME>tgtx_ex51.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 3 - file: tgtx_ex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23 <SEQUENCE>4 <FILENAME>tgtx_ex231.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 4 - file: tgtx_ex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tgtx_s3000.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tgtx_s3000.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>alstonlogo.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: alstonlogo.jpg
</DOCUMENT> </SEC-DOCUMENT>